Evaluation of MTA Pulpotomy, Biodentine Pulpotomy, and Glass Ionomer Indirect Pulp Treatment in Primary Teeth

HP-00058711

In primary teeth, decay that is near the pulp (tooth nerve)is treated with either a pulpotomy or indirect pulp treatment if the tooth is not going to be extracted A pulpotomy involves removing the top 1/2 of the pulp, placing a medication/material on the pulp, covering the remaining pulp with a cement, and the restoring the tooth. The purpose of this pilot study is to gain preliminary information regarding the success of Biodentine, MTA, and IPT in the treatment of deep decay in children's primary molars.

2018-07-01

2025-02-01

2025-02-01

Active (not recruiting)

Early phase I

76

Inclusion Criteria: * Pediatric patients with deep dental decay in primary molars * Teeth with signs and symptoms of reversible pulpitis Exclusion Criteria: * Teeth with clinical symptoms of irriversible pulpitis or pulp necrosis or acute dental infection * Children with systemic illness that contraindicated vital pulp treatment such a sickle cell disease * Teeth that are not restorable

{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE4'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['PARTICIPANT', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 76, 'type': 'ESTIMATED'}}

2024-02-26